Electron microscopy images of SARS-CoV-2 virus-like particles developed by CUNY School of Medicine and TechnoVax. (Image from City College of New York)
The CUNY School of Medicine at The City College of New York and TechnoVax announced a breakthrough in developing a COVID-19 vaccine.
Scientests from the collaborating organizations said in a news release that they have generated and characterized SARS-CoV-2 virus-like particles, which are structural mimics of the native virus in size, morphology and surface composition, but without viral, infection-causing genetic material.
According to the researchers, the features of the virus-like particles make it an “ideal candidate” for developing a COVID-19 vaccine candidate, as the technology has aided the successes of vaccines directed against HPV and hepatitis B.
“This innovation is most likely to accelerate the development of a COVI…